The Nantes University Hospital has just obtained funding from the Mutuelles AXA to carry out a large-scale research project over the next 3 years based on data and samples from the OMIN registry.
This project is led by Dr Fleur LORTON, pediatrician at the pediatric emergency department of the CHU.
The objective of the BIOMINRISK research project is to identify new biological markers of SUDI for a better understanding of its mechanisms around three axes: genetic, neurobiological and radio-anatomical. Ultimately, the BIOMINRISK project aims to reduce the number of avoidable deaths related to SUDI in France and in other countries through personalized prevention actions made possible by these new biomarkers.
Regular communications will be made to inform on the progress of this project.
